ATE548042T1 - Prostansäurederivate zur senkung des augeninnendrucks - Google Patents
Prostansäurederivate zur senkung des augeninnendrucksInfo
- Publication number
- ATE548042T1 ATE548042T1 AT02746356T AT02746356T ATE548042T1 AT E548042 T1 ATE548042 T1 AT E548042T1 AT 02746356 T AT02746356 T AT 02746356T AT 02746356 T AT02746356 T AT 02746356T AT E548042 T1 ATE548042 T1 AT E548042T1
- Authority
- AT
- Austria
- Prior art keywords
- prostone
- lowering
- acid derivatives
- co2r
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/859,770 US6531504B2 (en) | 2001-05-17 | 2001-05-17 | Prostanoic acid derivatives as agents for lowering intraocular pressure |
PCT/US2002/014580 WO2002092099A1 (en) | 2001-05-17 | 2002-05-07 | Prostanoic acid derivatives as agents for lowering intraocular pressure |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE548042T1 true ATE548042T1 (de) | 2012-03-15 |
Family
ID=25331661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02746356T ATE548042T1 (de) | 2001-05-17 | 2002-05-07 | Prostansäurederivate zur senkung des augeninnendrucks |
Country Status (9)
Country | Link |
---|---|
US (2) | US6531504B2 (de) |
EP (1) | EP1390036B1 (de) |
JP (1) | JP4606698B2 (de) |
AT (1) | ATE548042T1 (de) |
AU (1) | AU2002316081B2 (de) |
CA (1) | CA2446994C (de) |
DK (1) | DK1390036T3 (de) |
ES (1) | ES2381340T3 (de) |
WO (1) | WO2002092099A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875787B2 (en) * | 2003-02-11 | 2005-04-05 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
KR101077461B1 (ko) * | 2003-02-11 | 2011-10-26 | 알러간, 인코포레이티드 | 안압 강하제로서의 10,10-디알킬 프로스탄산 유도체 |
US7855226B2 (en) * | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
US7179820B2 (en) * | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
US7186744B2 (en) * | 2003-11-13 | 2007-03-06 | Allergan, Inc. | Prostamides for the treatment of glaucoma and related diseases |
US7169807B2 (en) * | 2004-04-09 | 2007-01-30 | Allergan, Inc. | 10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists |
WO2006041875A1 (en) | 2004-10-06 | 2006-04-20 | Allergan, Inc. | Novel prostamides for the treatment of glaucoma and related diseases |
US7101906B2 (en) | 2004-11-16 | 2006-09-05 | Allergan, Inc. | 2,3,4-substituted cyclopentanones as therapeutic agents |
US7893107B2 (en) * | 2005-11-30 | 2011-02-22 | Allergan, Inc. | Therapeutic methods using prostaglandin EP4 agonist components |
US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
US20090124695A1 (en) * | 2007-11-14 | 2009-05-14 | Cayman Chemical Company | Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
US20110020453A1 (en) * | 2009-02-06 | 2011-01-27 | Steven Blum | Topical Formulations Comprising Ion Channel Modulators |
KR101045935B1 (ko) | 2009-03-11 | 2011-07-01 | 연성정밀화학(주) | 프로스타글란딘 유도체의 제조방법 |
US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE37602B1 (en) * | 1971-05-11 | 1977-08-31 | Ici Ltd | Cyclopentane derivatives |
AR204816A1 (es) * | 1972-11-08 | 1976-03-05 | Pfizer | Procedimiento para preparar una prostaglandina |
US4994274A (en) | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
CA2021316C (en) | 1989-07-27 | 2000-10-24 | Ming Fai Chan | Intraocular pressure reducing 11-acyl prostaglandins |
US5034413A (en) | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
US5028624A (en) | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5972991A (en) * | 1992-09-21 | 1999-10-26 | Allergan | Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
CA2146127C (en) * | 1992-10-13 | 2000-06-13 | Louis Desantis, Jr. | Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
US5741810A (en) * | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
SE9702706D0 (sv) * | 1997-07-11 | 1997-07-11 | Pharmacia & Upjohn Ab | Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma |
DE69832513T2 (de) * | 1997-09-09 | 2006-07-13 | Duke University | Aromatische c16-c20-substituierte tetrahydro-prostaglandinen verwendbar wie fp agoniste |
MXPA01008955A (es) * | 1999-03-05 | 2002-04-24 | Procter & Gamble | Analogos de prostaglandinas selectivas de fp no saturadas de c16. |
-
2001
- 2001-05-17 US US09/859,770 patent/US6531504B2/en not_active Expired - Lifetime
-
2002
- 2002-05-07 AT AT02746356T patent/ATE548042T1/de active
- 2002-05-07 WO PCT/US2002/014580 patent/WO2002092099A1/en active Application Filing
- 2002-05-07 JP JP2002589016A patent/JP4606698B2/ja not_active Expired - Fee Related
- 2002-05-07 AU AU2002316081A patent/AU2002316081B2/en not_active Ceased
- 2002-05-07 DK DK02746356.1T patent/DK1390036T3/da active
- 2002-05-07 ES ES02746356T patent/ES2381340T3/es not_active Expired - Lifetime
- 2002-05-07 CA CA2446994A patent/CA2446994C/en not_active Expired - Fee Related
- 2002-05-07 EP EP02746356A patent/EP1390036B1/de not_active Expired - Lifetime
- 2002-11-13 US US10/294,521 patent/US6670485B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20020177620A1 (en) | 2002-11-28 |
WO2002092099A1 (en) | 2002-11-21 |
US6670485B2 (en) | 2003-12-30 |
JP4606698B2 (ja) | 2011-01-05 |
US20030105155A1 (en) | 2003-06-05 |
US6531504B2 (en) | 2003-03-11 |
EP1390036A1 (de) | 2004-02-25 |
CA2446994C (en) | 2011-02-01 |
JP2004530687A (ja) | 2004-10-07 |
CA2446994A1 (en) | 2002-11-21 |
ES2381340T3 (es) | 2012-05-25 |
AU2002316081B2 (en) | 2007-11-15 |
DK1390036T3 (da) | 2012-04-10 |
EP1390036B1 (de) | 2012-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE548042T1 (de) | Prostansäurederivate zur senkung des augeninnendrucks | |
WO2002089813A3 (en) | 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure | |
EA200300982A1 (ru) | Гетероциклические производные для лечения рака и других пролиферативных заболеваний | |
EA200401431A1 (ru) | Производные триазола в качестве антагонистов рецептора тахикинина | |
ATE318267T1 (de) | Einige alkylendiamin-substituierte heterocyclen | |
EA200101133A1 (ru) | Способ ингибирования агрегации амилоидных белков и визуализации амилоидных отложений с использованием производных изоиндолина | |
DE60226912D1 (de) | Chinolin- und Chianzolinderivate zur Behandlung von Tumoren | |
DK1063228T5 (da) | Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
DE69530094D1 (de) | Thiazolidindione derivate, ihre herstellung und verwendung | |
EA200500268A1 (ru) | Производные диоксан-2-алкилкарбаматов, способ их получения и применение в терапии | |
EA200300424A1 (ru) | Соли изотиазол-4-карбоксамида и их применение в качестве антигиперпролиферативных агентов | |
EA200300718A1 (ru) | Производные 3-индолина, которые могут применяться при лечении психиатрических и неврологических расстройств | |
EA200801895A1 (ru) | Производные хинолина и их применение в качестве пестицидов | |
DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
ATE469157T1 (de) | Tetrahydrofuroä3,4-düdioxolverbindungen und zusammensetzungen und verfahren zur inhibierung der trombozytenaggregation | |
EA200401519A1 (ru) | N- ациламинобензольные производные в качестве селективных ингибиторов моноаминооксидазы b | |
DK1157998T3 (da) | Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer | |
ATE402185T1 (de) | Verfahren für fluorcytidinderivate | |
ID24846A (id) | Turunan-turunan bifenilamidina | |
WO2002100388A3 (en) | Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension | |
ES2191341T3 (es) | Derivados de la 2-fenoxianilina. | |
MXPA05008431A (es) | Derivados de acido 10,10-dialquil prostanoico como agentes para reducir la presion intraocular. | |
RU2004130284A (ru) | Антипаразитарные производные артемизинина (эндопероксиды) | |
SE9904177D0 (sv) | Novel compounds | |
NO20033049L (no) | Fremgangsmåte for fremstilling av (+/-) trans-4-p-fluorfenyl- 3-hydroksymetyl-1-metylpiperidin |